We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+65.41%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$342M
AUM Growth
+$124M
Cap. Flow
+$19.5M
Cap. Flow %
5.71%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
STRO icon
Sutro Biopharma
STRO
+$27.6M

Top Sells

Rank Stock Value
1
ASXC
Asensus Surgical, Inc.
ASXC
+$4.76M
2
OCUL icon
Ocular Therapeutix
OCUL
+$3.28M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECX
1
Tectonic Therapeutic
TECX
$717M
$142M 41.55%
228,002
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$66.5M 19.46%
1,716,303
– –
KALV
3
DELISTED
KalVista Pharmaceuticals
KALV
$57M 16.7%
2,579,490
– –
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$38.5M 11.26%
510,141
-70,374
-12% -$4.76M
STRO icon
5
Sutro Biopharma
STRO
$353M
$27.4M 8.01%
+182,454
New +$27.6M
OCUL icon
6
Ocular Therapeutix
OCUL
$2.38B
$4.97M 1.46%
722,936
-522,334
-42% -$3.28M
XFOR icon
7
X4 Pharmaceuticals
XFOR
$419M
$3.03M 0.89%
10,383
– –
ATXS
8
DELISTED
Astria Therapeutics
ATXS
$2.29M 0.67%
47,628
– –
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
$6K ﹤0.01%
150,064
– –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q3 2018 Portfolio in Review

As of Q3 2018, SV Health Investors held 9 positions worth $342M, up 57% from $218M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $19.5M of net new capital in Q3 2018, opening 1 new position. Its largest new stake was Sutro Biopharma: 182,454 shares worth $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Asensus Surgical, Inc., an estimated $4.76M trimmed.

  • SV Health Investors's largest Q3 2018 buy was Sutro Biopharma: 182,454 shares worth $27.4M.
  • SV Health Investors's biggest Q3 2018 reduction was Asensus Surgical, Inc., cutting an estimated $4.76M.
  • SV Health Investors's ten largest holdings make up 100% of its $342M portfolio in Q3 2018.
  • SV Health Investors opened 1 new position and closed 0 in Q3 2018.
  • SV Health Investors's portfolio value rose 57% quarter-over-quarter to $342M.

Based on SV Health Investors's 13F filing for Q3 2018, filed 14 Nov 2018.